<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Song J</submitter><funding>National Natural Science Foundation of China</funding><pagination>1131-1141</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6072089</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(7)</volume><pubmed_abstract>Twenty-four 14-sulfonamide-tetrandrine derivatives as potential anti-cancer agents were synthesized. The synthetic derivatives were investigated for their cytotoxic activity against human cancer cell lines MDA-MB-231, PC3, WM9, HEL and K562. Initially, the IC&lt;sub>50&lt;/sub> values (50% inhibitory concentrations) of all of the compounds were determined. These derivatives exhibited potent, but distinct, inhibitory effects on the above-mentioned cell lines. Among them, compound &lt;b>23&lt;/b>, which was modified with a 2-naphthalenesulfonyl group at the 14-amino position, showed impressive inhibition of all five cancer cell lines, and especially of MDA-MB-231 cells with an IC&lt;sub>50&lt;/sub> value of 1.18 ± 0.14 μM. Further mechanism exploration showed that &lt;b>23&lt;/b> induced potent apoptotic cell death on MDA-MB-231 cancer cells in a concentration-dependent manner. The results revealed that &lt;b>23&lt;/b> might be a potential anti-cancer drug candidate.</pubmed_abstract><journal>MedChemComm</journal><pubmed_title>Design, synthesis and bioactivity investigation of tetrandrine derivatives as potential anti-cancer agents.</pubmed_title><pmcid>PMC6072089</pmcid><funding_grant_id>81472609</funding_grant_id><funding_grant_id>81360479</funding_grant_id><pubmed_authors>Ben-David Y</pubmed_authors><pubmed_authors>Pan W</pubmed_authors><pubmed_authors>Hu S</pubmed_authors><pubmed_authors>Lou H</pubmed_authors><pubmed_authors>Zeng X</pubmed_authors><pubmed_authors>Chen C</pubmed_authors><pubmed_authors>Song J</pubmed_authors><pubmed_authors>Lan J</pubmed_authors><pubmed_authors>Liu W</pubmed_authors></additional><is_claimable>false</is_claimable><name>Design, synthesis and bioactivity investigation of tetrandrine derivatives as potential anti-cancer agents.</name><description>Twenty-four 14-sulfonamide-tetrandrine derivatives as potential anti-cancer agents were synthesized. The synthetic derivatives were investigated for their cytotoxic activity against human cancer cell lines MDA-MB-231, PC3, WM9, HEL and K562. Initially, the IC&lt;sub>50&lt;/sub> values (50% inhibitory concentrations) of all of the compounds were determined. These derivatives exhibited potent, but distinct, inhibitory effects on the above-mentioned cell lines. Among them, compound &lt;b>23&lt;/b>, which was modified with a 2-naphthalenesulfonyl group at the 14-amino position, showed impressive inhibition of all five cancer cell lines, and especially of MDA-MB-231 cells with an IC&lt;sub>50&lt;/sub> value of 1.18 ± 0.14 μM. Further mechanism exploration showed that &lt;b>23&lt;/b> induced potent apoptotic cell death on MDA-MB-231 cancer cells in a concentration-dependent manner. The results revealed that &lt;b>23&lt;/b> might be a potential anti-cancer drug candidate.</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Jul</publication><modification>2025-04-19T21:01:04.862Z</modification><creation>2019-06-06T23:04:02Z</creation></dates><accession>S-EPMC6072089</accession><cross_references><pubmed>30109000</pubmed><doi>10.1039/c8md00125a</doi></cross_references></HashMap>